Immune checkpoint inhibitor dosing: Can we go lower without compromising clinical efficacy?

Alex Renner, Mauricio Burotto, Carlos Rojas

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint Dive into the research topics of 'Immune checkpoint inhibitor dosing: Can we go lower without compromising clinical efficacy?'. Together they form a unique fingerprint.

Chemical Compounds

Engineering & Materials Science

Medicine & Life Sciences